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Abstract— In this study, we evaluated the effects of 
hyperglycemia on the variability of RR (HRV), QT interval 
variability (QTV) and corrected QT interval variability (QTcV) 
during hyperglycemic and non-hyperglycemic conditions in six 
Type 1 diabetic patients at nights. The aim of this study was to 
investigate the association of high blood glucose levels with 
autonomic modulation of heart rate and variation in 
ventricular repolarization. Blood glucose level (BGL) threshold 
for defining hyperglycemia state was set at 8.33 mmol/l. 
Variability of RR, QT and corrected QT intervals during 
hyperglycemic and non-hyperglycemic were quantified using 
time and frequency domain measures. Hypomon® device was 
used to monitor ECG signals and acquire RR and QT intervals 
in Type 1 diabetic patients overnight. The results indicated that 
time and frequency domain HRV variables were significantly 
decreased under hyperglycemic condition and inversely 
correlated with BGL. QTV parameters also reduced when BGL 
increased and time domain measures of QTV were inversely 
associated with BGL. Variability in QTc interval was much less 
than in the QT interval and demonstrated a lower SDNN and 
LF power. We concluded that certain components of HRV, 
time-domain measures of QTV and QTc but not QTcV are 
strongly correlated to high blood glucose levels and can be good 
markers to identify hyperglycemic events in T1DM. 
 
Variability of RR as known as Heart rate variability 
(HRV) measures has a close relationship to sympathetic and 
parasympathetic branches of the autonomic nervous system 
(ANS) [1].  These branches are linked to the heart at the 
sinoatrial node (SA) where the beat is initiated for a normal 
heart. The sympathetic branch will raise heart rate, blood 
sugar and blood pressure under stress while the 
parasympathetic branch will have an opposite effect once the 
body gets rest and relaxation [2]. The use of HRV has 
emerged as a simple, reliable and non-invasive method to 
evaluate the sympatho-vagal balance at the sinoatrial level. In 
addition, diabetes mellitus is one of the main causes of 
autonomic neuropathy, which can lead to abnormalities in 
heart rate control [3]. Therefore, it is no doubt that there is 
association between HRV changes and diabetic patients. 
 Abnormalities of autonomic activity reflected by reduced 
HRV are strongly associated with increased risk for cardiac 
events and mortality [4, 5]. HRV is influenced by a variety of 
physiological stimuli and all attention has been focused on 
various ways of analyzing the variation of RR interval or 
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heart rate. However, it is known that specific branches of the 
autonomic nervous system may influence difference parts of 
the cardiac cycle to differing degrees. For example, the 
cardiac cycle length (the RR interval) and repolarization (QT 
interval) are independently controlled by the autonomic 
system [6].   
QT interval variability (QTV) reflects temporal 
fluctuations in duration of ventricular repolarization. The 
origins of QTV, particularly the influences of autonomic 
nervous system activity, remain incompletely understood [7]. 
Nevertheless, QTV is considered to provide a non-invasive 
measure of susceptibility to ventricular arrhythmias [8]. 
The variation analysis can be accomplished in the time or 
frequency domain. The time domain analysis, the simpler 
way, calculates a number of variables that describe beat to 
beat changes. The frequency domain components of HRV 
signal, derived from its power spectrum analysis, has been 
commonly used to quantify the relative dominance of 
parasympathetic and sympathetic influence on the heart [9]. 
These measures are sensitive indicators of autonomic 
function in diabetic patients [1]  and may provide important 
insight into the pathogenesis of autonomic neuropathy in 
hyperglycemia [10]. Typically, frequency domain has been 
divided into three major groups: high, low and very low 
frequency bands. High frequency (0.15-0.4 Hz) is thought to 
represent the parasympathetic component of the autonomic 
nervous system. Low frequency (0.04-0.15 Hz) is mediated 
by both parasympathetic and sympathetic nervous system. 
Very low frequency (0.0033-0.04 Hz) is influenced by many 
factors, including thermoregulation and the rennin-
angiotensin system [11].   
Recently, reduced HRV has been seen among patients 
with Type 1 diabetic mellitus [12, 13] and the main driver to 
this abnormality appears to be hyperglycemia. 
Hyperglycemia has also been reported with significant 
decrease in QT interval and corrected QT interval (by 
Bazett’s formula) [14, 15]. To our knowledge, there has not 
been studied previously about the variability of QT interval 
(QTV) and variability of corrected QT interval (QTcV) 
related to hyperglycemia. Therefore, we now propose the 
methodology to study RR, QT and corrected QT interval 
changes simultaneously in both time and frequency domains 
under hyperglycemic condition and non-hyperglycemic 
condition. We also examine the strength of the association of 
high blood glucose levels with variations in RR interval, QT 
interval and corrected QT interval. Section II presents an 
overview of the method used in our study. Results of the 
study and discussion will be mentioned in section III. Finally, 
section IV provides the conclusion for this study.   
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Six patients with T1DM have been studied for overnight 
glycemia monitoring at the Princes Margaret Hospital for 
Children in Perth, Australia. Each patient was monitored 
overnight for the natural occurrence of hypoglycemia and 
hyperglycemia. Data were collected with approval from 
Women’s and Children’s Health Service, Department of 
Health, Government of Western Australia, and with informed 
consent. 
HypoMon® from AIMedics Pty Ltd was used to 
continuously measure and record electrocardiographic (ECG) 
signals every minute during night. This medical device also 
provided required ECG parameters (RR interval, QT interval 
and corrected QT interval by Bazett’s formula). Data from 
HypoMon® is all clean signals to make sure artifacts and 
ectopic beats have been eliminated. Actual blood glucose 
levels (BGLs) were collected as reference using Yellow 
Spring Instruments. In our study, the BGL threshold to define 
hyperglycemia is set at 8.33 mmol/l. BGL was sampled every 
30-minute duration from 9 pm to 6 am corresponding to 














B. Variability assessment 
RR, QT and QTc intervals were analyzed off-line using 
purpose-written software written in Matlab to calculate the 
time-domain, frequency domain parameters from raw 
RR/QT/QTc signals. Baseline drift in data were subtracted by 
a data-smoothing algorithm. In time domain, we measured 
mean RR interval, the standard deviation of the RR interval 
index (SDNN), the root mean square of successive RR 
interval differences (RMSSD) and the percentage of beats 
with a consecutive RR interval > 50 ms. SDNN is considered 
to reflect both sympathetic and the parasympathetic influence 
on HRV [5]. The other parameters are considered to reliable 
indices of cardiac parasympathetic activity [16]. Frequency 
domain analysis was done by fast Fourier transform using 
Hanning window to derive spectral power. The intervals were 
linearly interpolated at the rate of 5 Hz to obtain evenly 
sampled values. The power of LF, HF and VLF components 
is usually expressed in absolute units (ms
2). The ratio 
between LF and HF components (LF/HF ratio) is used to 
reflect the balance between sympathetic and parasympathetic 
parts of the autonomic system and hence shows the level of 
sympathetic dominance (stress) in a subject [17]. These time 
and frequency domains parameters are considered to be most 
physiologically linked to the autonomic nervous system.  
C. Statistical analysis 
 Independent t-test was applied to every parameter to 
estimate the significant differences between hyperglycemia 
and non-hyperglycemia conditions. Moreover, Pearson’s 
correlation analyses were used to evaluate and test the 
strengths of association between BGLs and variables in time 
and frequency domains. All statistical analyses were 
conducted with IBM SPSS version 19 (SPSS Inc, Chicago, 
IL, USA). Significance value (p-value) less than 0.05 is 
considered to be significant. Results are presented as mean ± 
standard errors. 
 
III. RESULTS AND DISCUSSION 
A. Heart Rate Variability  
Six out of eight time and frequency domain parameters 
were significant decreased under hyperglycemic condition 
compared to non-hyperglycemic condition (as shown in 
Table I). Mean RR and LF/HF ratio were also reduced but 
did not achieve statistical significance. This result concurs 
with other reports that described lower HRV measures in 
diabetic patients than in normal subjects [3, 12, 17]. Table II 
demonstrated that BGLs were inversely and significantly 
correlated with SDNN, RMSSD, pNN50 and LF and HF 
(p<0.05). It reveals that SDNN appears to be the most 
significant parameter in HRV with a strong relation with high 
BGL. 




Hyper Non-hyper p value 
Mean RR (ms) 910.968 ± 83.002 929.856 ± 115.096 0.565 
SDNN (ms) 45.499 ± 15.125 74.099 ± 27.858 < 0.0001 
RMSSD (ms) 57.208 ± 22.503 86.884 ± 41.922 0.018 
pNN50 (ms) 28.629 ± 16.676 46.085 ± 17.971 0.003 
VLF (ms2) 49.055 ± 59.687 353.037 ± 430.255 0.001 
LF (ms2) 320.968 ± 252.754 1202.476 ± 1097.324 0.001 
HF (ms2) 886.154 ± 1109.992 1618.507 ± 1669.221 0.012 
LF/HF 0.766 ± 0.719 1.323 ± 1.669 0.328 
 
TABLE II.  CORRELATIONS BETWEEN HRV AND BLOOD GLUCOSE 
LEVELS 
Variables Coefficient r p value 
Mean RR  -0.034 0.842 
SDNN  -0.473 0.004 
 




Variables Coefficient r p value 
RMSSD  -0.373 0.025 
pNN50  -0.522 0.001 
VLF  -0.322 0.056 
LF  -0.379 0.023 
HF  -0.372 0.025 
LF/HF -0.199 0.246 
 
B. QT Variability 
 Summary data on QTV were tabulated in Table III and 
IV. Except LF/HF ratio, all other parameters in time and 
frequency domains were significantly lower in hyper events 
than in non-hyper events (p< 0.05). However, when 
correlation analysis was used, only time domain parameters 
(Mean QT, SDNN-QT, RMSSD-QT) showed significant 
relation with high BGLs (r = -0.429, p = 0.004; r = -0.429, p 
= 0.004; r = -0.429, p = 0.004; respectively) but not 
frequency domain parameters (p> 0.05).  




Hyper Non-hyper p value 
Mean QT (ms) 379.253 ± 10.753 392.58 ± 19.86 0.02 
SDNN-QT (ms) 8.143 ± 2.728 12.333 ± 5.749 0.002 
RMSSD-QT 
(ms) 
9.78 ± 3.615 15.584 ± 7.7 0.001 
VLF-QT (ms2) 0.877 ± 1.015 2.457 ± 3.601 0.034 
LF-QT (ms2) 3.601 ± 3.375 11.659 ± 18.118 0.027 
HF-QT (ms2) 9.419 ± 7.795 33.706 ± 47.488 0.012 
LF/HF-QT 0.395 ± 0.189 0.831 ± 2.48 0.503 
 
TABLE IV.  CORRELATIONS BETWEEN QTV AND BLOOD GLUCOSE 
LEVELS 
Variables Coefficient r p value 
Mean QT  -0.429 0.004 
SDNN-QT  -0.315 0.037 
RMSSD-QT  -0.351 0.02 
VLF-QT  -0.157 0.308 
LF-QT  -0.158 0.305 
HF-QT  -0.166 0.282 
LF/HF-QT -0.014 0.93 
 
C. QTc Variability 
 QTcV measures were described below in Table V and VI. 
It can be seen that time domain features were significantly 
shorter under hyper condition than under non-hyper 
condition. In frequency domain, only HF component was 
significantly decreased (67.35 ± 65.408 vs. 244.452 ± 
343.639, p = 0.019). VLF, LF and LF/HF ratio tend to be 
smaller in hyper compared to non-hyper, but these 
differences were not statistically significant (p> 0.05). In 
addition, mean QTc seems to be the most related variable to 
high BGL (r = -0.497, p = 0.001) while RMSSD-QT had 
slight association with high BGL (r = -0.32, p = 0.041). 
Other parameters did not show any statistical correlations 
with BGL.  
TABLE V.  CORRECTED QT VARIABILITY UNDER HYPERGLYCEMIC 
AND NON-HYPERGLYCEMIC CONDITIONS 
QTcV 
measures 
Hyper Non-hyper p value 
Mean QTc (ms) 395.818 ± 26.789 423.392 ± 27.053 0.003 
SDNN-QTc 
(ms) 
18.12 ± 6.694 28.922 ± 19.405 0.039 
RMSSD-QTc 
(ms) 
21.625 ± 8.874 33.445 ± 17.732 0.018 
VLF-QTc (ms2) 3.779 ± 4.558 52.866 ± 155.678 0.217 
LF-QTc (ms2) 19.47 ± 16.614 245.968 ± 773.99 0.251 
HF-QTc (ms2) 67.35 ± 65.408 244.452 ± 343.639 0.019 
LF/HF-QTc 0.427 ± 0.321 0.599 ± 0.634 0.322 
 
TABLE VI.  CORRELATIONS BETWEEN QTCV AND BLOOD GLUCOSE 
LEVELS 
Variables Coefficient r p value 
Mean-QTc  -0.497 0.001 
SDNN-QTc  -0.226 0.155 
RMSSD-QTc  -0.32 0.041 
VLF-QTc  -0.083 0.604 
LF-QTc  -0.068 0.672 
HF-QTc  -0.157 0.326 
LF/HF-QTc -0.07 0.663 
 
D. Discussion 
  Recent studies have emphasized the importance of HRV 
in evaluation of autonomic nervous system on the heart rate. 
Our study demonstrated that it is possible to use time 
domain measures and power spectral techniques to analyze 
autonomic influence on the cardiac cycle length and 
ventricular repolarization. In agreement with previous 
studies, high blood glucose levels caused lower HRV in 
subjects with diabetes. Our findings extended the previous 
observations made in selected T1DM patients and went 
across the spectrum of hyperglycemia and non-
hyperglycemia events. SDNN was much lower in 
hyperglycemic events than in non-hyperglycemic events 
means that both the sympathetic and parasympathetic 
influence on HRV. SDNN is probably the best known HRV 
  
index [5], mostly used as a time domain measure of HRV, 
because the additional information from other time domain 
parameters of HRV is relatively scant. In frequency domain 
measurements, LF can be used to quantify the sympathetic 
component of autonomic function in addition to HF, the 
parasympathetic component. Our results showed that both 
these two features were significantly decreased under 
hyperglycemic condition.  Therefore, SDNN, LF and HF 
could be good markers to identify hyperglycemic and non-
hyperglycemic states using HRV in T1DM. 
 
 There is little known of QTV in both time and frequency 
domain measurements among diabetes population. Recently, 
variability of QT interval is also considered to be able to 
reflect the variation of ventricular repolarization under the 
influence of the autonomic system in patients with ischemic 
heart disease [18]. Data from our study confirm these 
findings also true in diabetes patients by demonstrating the 
reduction in almost QTV measures. Since the QTc interval 
was derived to be independent of heart rate, the observed 
variation of QTc, at least partially, represent a direct 
modulation of ventricular repolarization by the autonomic 
system.  The QTc variability in frequency domain has not 
been investigated in diabetes patients before. Clearly, QTV 
and QTcV are significantly smaller than HRV. QTcV seems 
to reflect parasympathetic function in the context of high 
blood glucose due to only HF component showed significant 
difference. We also explored the relations between variables 
in QTv and QTcV with BGL. Unlike HRV, only time 
domain measures of QTV and duration of QTc interval are 
related to hyperglycemia.  It still remains unclear why only 
time domain measurements show relations with high blood 
glucose levels, probably because origin of QT variability as 
well as QTc variability are incompletely understood. Further 
studies with larger population are essential to draw definite 
conclusion. Meanwhile, time domain measures of QTV and 
QTc interval still proved to capable in clarifying states of 
hyper and non-hyper. 
 
IV. CONCLUSION 
In conclusion, our study demonstrated that variability of 
RR, QT, and QTc intervals are reduced in patients with 
T1DM under hyperglycemic condition. We believe this is 
the first report to identify abnormal QT variability and QTc 
variability in hyperglycemia. Certain measures of HRV, time 
domain measures of QTV and QTc but not QTcV have 
associations with high blood glucose. These variables are 
feasible input to classify states of hyperglycemia or non-
hyperglycemia in T1DM. The prognostic value of these 
findings remains unknown. Additional clinical studies are 
needed to determine the mechanisms in the reduction of 
HRV, QTV and QTcV related to high blood glucose levels. 
Knowledge of HRV as well as QTV and QTcV may 
influence the aggressive of intervention and the choice of 
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